Lifestyle, exercise, diet, and supplements

Synthesis of the evidence on non-drug lifestyle interventions for RLS: aerobic/resistance exercise, yoga and relaxation-based mind-body practice, cognitive behavioural approaches, massage/reflexology and cold-water hydrotherapy, diet and modifiable risk factors (weight/bariatric surgery, smoking, alcohol, caffeine), and supplements (magnesium, vitamin D, vitamin C/E, vitamin B6, Pycnogenol). All claims below cite a study note filename (in knowledge-base/studies/) or a PMID. Medical disclaimer: nothing here is individual medical advice; any change to RLS medication, especially tapering a dopamine agonist, must be done only under physician supervision and never stopped abruptly (see docs/00_MASTER_PLAN.md section 2 and the dopamine-agonists-augmentation.md topic synthesis for DAWS risk).

What is established (grade A/B)

• Structured exercise reduces RLS symptom severity in RCTs, both in idiopathic RLS and in the much-better-studied hemodialysis-associated RLS population. The founding general-population RCT found a 12-week aerobic-plus-resistance program significantly beat control on the IRLSSG scale (p=.001) and an ordinal severity scale (p<.001) (2006-aukerman-exercise-rct.md). In hemodialysis patients, a controlled trial isolating true training effect found 6 months of progressive intradialytic cycling cut severity by 58% (p=0.003) versus a non-significant 17% with matched zero-resistance cycling (2013-giannaki-aerobic-exercise-uremic-rct.md), and a meta-analysis of 15 RCTs confirmed exercise training significantly improves RLS, depression, and fatigue in hemodialysis patients (all p<0.001; 2017-song-exercise-hemodialysis-meta-analysis.md), consistent with a broader systematic review of exercise across hemodialysis-related symptoms (2021-hargrove-aerobic-exercise-hemodialysis-symptoms.md) and a 2018 systematic review of RCTs across all non-pharmacologic RLS interventions (2018-harrison-nonpharm-systematic-review.md).
• In hemodialysis patients, supervised exercise training can rival a low-dose dopamine agonist. A 6-month three-arm RCT found exercise reduced severity 46% versus 54% with ropinirole 0.25 mg/day (both active arms significantly better than placebo), with exercise additionally increasing lean body mass (p=0.014), a benefit the drug did not provide (2013-giannaki-exercise-dopamine-agonist-comparison.md). Combining intradialytic exercise with a low dopamine-agonist dose achieved about a 60% symptom reduction regardless of whether the drug or a placebo was added to the exercise, suggesting exercise itself may permit a lower effective drug dose (2015-giannaki-exercise-dopamine-agonist-combination.md). A large network meta-analysis of 12 RCTs (498 patients) found exercise-plus-dopamine-agonist combination therapy ranked favorably on both efficacy (SMD 1.60, 95% CI 0.08-3.12) and acceptability compared with gabapentin alone (2020-huang-network-meta-analysis-esrd-treatments.md), and an updated 24-RCT (1,252-patient) component network meta-analysis found intradialytic stretching exercise (MD 12.00, 95% CI 7.04-16.97) numerically outperformed gabapentin (MD 8.90-8.95) for severity reduction, though with lower confidence in the evidence (2022-chen-component-network-meta-analysis-eskd.md).
• Antioxidant vitamins C and E significantly reduce RLS severity in hemodialysis patients. A 60-patient, double-blind, placebo-controlled RCT found vitamin C, vitamin E, and their combination all significantly beat placebo (p<0.001 for each), with no added benefit of combining them (2012-sagheb-vitamin-c-e-hemodialysis-rct.md); this is corroborated in the 2024 network meta-analysis (2022-chen-component-network-meta-analysis-eskd.md) and the most current dietary-supplement systematic review (2024-gonzalez-parejo-dietary-supplements-systematic-review.md).
• Magnesium (as magnesium oxide) and vitamin B6 significantly reduce RLS severity and improve sleep quality, but the effect may take about two months to appear. A 75-patient RCT found no significant difference between magnesium, vitamin B6, and placebo at 1 month, but a significant benefit for both active arms by 2 months (p=.001) (2022-jadidi-magnesium-b6-rct.md), a timeline consistent with the 2024 systematic review's conclusion that magnesium was the more effective of the two (2024-gonzalez-parejo-dietary-supplements-systematic-review.md).
• Yoga improves RLS symptoms beyond an active, attention-matched control. The largest RCT to date (41 randomized, 30 completers) found 12 weeks of yoga significantly outperformed an educational-film control on RLS symptoms/severity (p≤.01), with 77% of yoga participants reaching minimal/mild severity versus 24% on film, and a dose-response relationship between home-practice minutes and symptom improvement (r=.6-.7, p≤.03) (2020-innes-yoga-educational-film-rct.md).
• Cognitive behavioural approaches help RLS-related insomnia and psychosocial burden. A 25-patient RCT found four sessions of CBT for insomnia significantly improved insomnia severity, sleep efficiency, and anxiety versus a single sleep-hygiene session, sustained to 3 months (2020-song-cbti-rls-comorbid-insomnia-rct.md).
• Progressive muscle relaxation significantly reduces RLS intensity and improves sleep and quality of life in pregnant women, a population where pharmacological options are especially constrained (52-patient RCT, p=.000-.001; 2023-akbas-progressive-muscle-relaxation-pregnancy-rct.md).
• Modifiable lifestyle factors reduce RLS risk at the population level. A prospective cohort of 55,540 US health professionals found normal body weight, physical activity, non-smoking, and moderate alcohol intake were each associated with lower RLS risk, with a clear dose-response across the number of healthy factors present (adjusted OR 0.67, 95% CI 0.47-0.97, for 4 versus 0 factors; p for trend <0.001) (2016-batool-anwar-lifestyle-factors-cohort.md).
• Massage-based touch therapy has RCT-level support in hemodialysis-associated RLS. A 58-patient RCT found intradialytic massage with 5% lavender oil significantly reduced RLS severity across all follow-up weeks and improved multiple kidney-disease quality-of-life subscales versus a baby-oil control (2021-doner-lavender-massage-hemodialysis-rct.md), and a 90-patient three-arm RCT found foot reflexology significantly outperformed both Swedish massage and a sham-touch control immediately post-intervention (P<0.001 for both comparisons) (2022-ghanbari-reflexology-swedish-massage-rct.md).
• A 2016 Cochrane systematic review of 9 CKD-RLS trials (220 patients) corroborates the exercise-severity benefit above: aerobic resistance exercise significantly beat both no-exercise (MD -7.56, 95% CI -14.20 to -0.93) and no-resistance-exercise controls (MD -11.10, 95% CI -17.11 to -5.09) (2016-gopaluni-cochrane-ckd-rls-interventions.md) — see Contested/negative below for this review's more cautious overall verdict.

Emerging C

• Yoga's earliest pilot data (uncontrolled) showed very large effect sizes (Cohen's d 1.6-2.2) and a practice-time dose-response in a small sample of women (2012-innes-yoga-pilot-women.md), and a nested RCT in older women found yoga improved sleep, mood, and blood pressure versus an educational film (large effect sizes 1.9-2.6) but was not powered on RLS severity itself (2012-innes-yoga-older-women-nested-rct.md).
• Magnesium citrate monotherapy (open-label, uncontrolled, n=12) improved IRLSSG score (p=.006) and objective periodic-limb-movement-during-wakefulness measures without a significant rise in serum magnesium, an intriguing but unconfirmed signal that awaits a placebo-controlled trial (2024-gorantla-magnesium-citrate-open-label-pilot.md).
• Pycnogenol (French maritime pine bark extract), tested in a small, non-randomized registry study (n=45), showed significant improvement across multiple vascular and symptom measures, with a plausible antioxidant/venoarteriolar mechanism, but the lack of randomization limits confidence (2022-belcaro-pycnogenol-registry-study.md).
• An RLS-specific cognitive behavioural group therapy program ("RELEGS") improved RLS-related quality of life and mental health in a 25-patient, single-arm proof-of-concept trial, sustained to 3 months, but has not yet been tested against a control group (2008-hornyak-cbt-group-therapy-coping.md).
• Exercise-based interventions extend to comorbid neurological populations: a pilot RCT of a physical activity behaviour-change program in multiple sclerosis (n=15) improved RLS severity across several contexts (p=.01-<.01) (2021-cederberg-physical-activity-ms-pilot-rct.md), and an 8-week exergaming RCT in MS-RLS (n=26 with RLS) improved severity, anxiety, sleep, and balance, with benefits preserved at 8-week follow-up (2022-ozdogar-exergaming-ms-rct.md) — promising but not yet generalizable beyond MS.
• The earliest intradialytic exercise studies (uncontrolled or non-randomized pilots) established feasibility and a large symptom benefit (IRLS score down 42%, p=.02) but used weaker designs than the later Giannaki RCTs (2008-sakkas-intradialytic-exercise-pilot.md), and a single-session mechanistic study showed even one bout of intradialytic cycling acutely suppresses periodic limb movements in RLS patients regardless of intensity (2010-giannaki-single-bout-exercise-plm-hemodialysis.md).
• Self-applied cold-water hydrotherapy (twice-daily Kneipp-style cold knee/lower-leg affusions) and 6-point acupressure each showed numerically better IRLS scores and RLS-specific quality of life than routine care alone in a 54-patient, three-arm, exploratory pilot RCT — the first RCT-level quantitative data on a "cold bath"-type intervention long recommended anecdotally, though not powered for confirmatory significance testing (2025-kubasch-hydrac-hydrotherapy-acupressure-rct.md).
• Weight loss is associated with RLS improvement. A 454-patient pre/post cohort of bariatric-surgery patients found RLS severity scores fell significantly after surgery, with the amount of BMI reduction correlating with the amount of RLS improvement (r=-0.41, p<0.05) (2025-mutlu-bariatric-surgery-sleep-rls-cohort.md), consistent with an earlier small case series in which 12 of 14 patients discontinued RLS medication after sleeve gastrectomy alongside a mean BMI drop from 46.5 to 28.3 kg/m² (2019-ozdas-bariatric-surgery-rls-case-series.md); neither study had a control group, so causation cannot be confirmed.

Contested or negative findings

• Not all exercise protocols work. A small RCT (n=18) of once-weekly "tension and trauma release" stretching exercises found no significant difference from a supportive discussion-group control at 6 weeks, even though both groups improved over time — a caution that low-frequency or non-aerobic exercise protocols may be under-dosed compared with the 3x/week aerobic-plus-resistance regimens that did show clear benefit (2018-harrison-novel-exercises-rct.md).
• Magnesium's evidence base is genuinely mixed. A 2019 systematic review found only 8 usable studies (one RCT, showing no significant effect, plus case series/reports) and explicitly concluded no conclusion could be drawn about magnesium's efficacy (2019-marshall-magnesium-systematic-review.md) — in tension with the later, more positive Jadidi 2022 RCT and Gorantla 2024 open-label pilot above; the discrepancy may reflect dose, formulation (oxide vs citrate), or duration differences, or simply the weak evidentiary base as of 2019.
• Vitamin D supplementation, despite biological plausibility, has not shown benefit in the one dedicated double-blind RCT: 50,000 IU/week for 12 weeks raised serum vitamin D but produced no significant improvement in RLS severity versus placebo (2018-wali-vitamin-d-replacement-rct.md), a negative result echoed by the 2024 dietary-supplement systematic review, which likewise found no significant benefit for vitamin D across the RCTs it pooled (2024-gonzalez-parejo-dietary-supplements-systematic-review.md).
• Caffeine avoidance and general "healthy eating" diet quality, despite common lay advice, were not significantly associated with RLS risk in the large Batool-Anwar cohort, in contrast to the significant effects of weight, exercise, smoking, and alcohol (2016-batool-anwar-lifestyle-factors-cohort.md). Caffeine's role is genuinely contested in the wider literature: a smaller, weaker 331-student cross-sectional survey found higher self-reported caffeine intake associated with RLS (42.9% RLS prevalence in students drinking 3-4 cups/day versus 18.6% in others) (2025-alabdulqader-caffeine-smoking-medical-students.md) — the cross-sectional design cannot rule out reverse causation (RLS-driven fatigue prompting more caffeine use) or confounding, so the larger, prospective Batool-Anwar cohort should be weighted more heavily.
• A 2016 Cochrane systematic review of intradialytic exercise and other CKD-RLS interventions, despite finding a significant benefit of aerobic resistance exercise over no-exercise and no-resistance-exercise controls, explicitly concluded that "pharmacological interventions and intra-dialytic exercise programs have uncertain effects on RLS in haemodialysis patients," citing small trial sizes, short follow-up, and substantial heterogeneity (I²=65% for the pooled exercise comparison) (2016-gopaluni-cochrane-ckd-rls-interventions.md) — a useful, grade-A-level check against over-reading the more optimistic individual RCTs summarized above.
• Massage benefits may not persist without ongoing treatment: in the three-arm reflexology/Swedish-massage RCT, the significant immediate post-intervention improvement in RLS severity and sleep quality had disappeared by one-month follow-up in all three groups, including the sham-touch control (2022-ghanbari-reflexology-swedish-massage-rct.md).
• Symptom-scale improvement does not always translate into quality-of-life improvement: a 26-patient hemodialysis RCT found aerobic exercise significantly improved RLS signs but not overall quality of life (2013-mortazavi-aerobic-exercise-esrd-rct.md).
• Exercise type matters and not all forms are equal in dialysis-associated RLS: in the largest network meta-analysis to date, intradialytic aerobic exercise alone was not statistically significant for either severity (MD 3.83, 95% CI -4.87 to 12.53) or sleep quality (SMD -0.10, 95% CI -0.84 to 0.64), while intradialytic stretching exercise was significantly effective for severity — a distinction obscured when "exercise" is treated as a single category (2022-chen-component-network-meta-analysis-eskd.md).

Mechanistic picture in 5 bullet points

• Exercise's benefit in RLS appears to be a true training/systemic-adaptation effect, not simply distraction or repetitive leg movement: a trial that matched movement but varied training load (cycling with versus without resistance) found only the loaded, progressively-adapted training group improved significantly (2013-giannaki-aerobic-exercise-uremic-rct.md).
• Movement also has a separate, acute, same-session effect: a single bout of intradialytic cycling transiently suppresses periodic limb movements during that dialysis session regardless of intensity, consistent with the general RLS/PLM relief-by-movement phenomenon described in the core pathophysiology, independent of any chronic training adaptation (2010-giannaki-single-bout-exercise-plm-hemodialysis.md).
• Antioxidant supplementation (vitamin C, E) benefits uraemic RLS specifically, plausibly via reduction of the oxidative stress associated with chronic kidney disease and dialysis, but whether this pathway is relevant to iron-deficiency/dopaminergic idiopathic RLS (the population on long-term dopamine agonists or alpha-2-delta ligands that this project targets) is untested (2012-sagheb-vitamin-c-e-hemodialysis-rct.md).
• Non-exercise physical interventions with the largest measured effect in dialysis-associated RLS (cool dialysate, intradialytic stretching) point toward a distinct, likely peripheral/thermoregulatory or sensory-nerve-conduction mechanism, separate from the central brain-iron-dopamine axis described elsewhere in this knowledge base (2022-chen-component-network-meta-analysis-eskd.md) — a mechanism family that plausibly also covers touch-based (massage, reflexology) and cold-water hydrotherapy interventions, though no study has directly tested cutaneous/thermoregulatory afferent pathways as the mediator (2021-doner-lavender-massage-hemodialysis-rct.md, 2025-kubasch-hydrac-hydrotherapy-acupressure-rct.md).
• Mind-body and behavioural interventions (yoga, progressive muscle relaxation, CBT) consistently improve perceived stress, sleep quality, and mood alongside RLS severity, suggesting they may act at least partly by reducing the arousal/hyperarousal state proposed in RLS pathophysiology (the master plan's glutamatergic/adenosinergic hyperarousal mechanism) rather than by directly correcting brain iron or dopaminergic dysfunction (2020-innes-yoga-educational-film-rct.md, 2020-song-cbti-rls-comorbid-insomnia-rct.md).

Implications for a non-drug long-term plan for people currently on dopamine agonists or alpha-2-delta ligands

• Recommend structured exercise (aerobic plus resistance training, at least 3 sessions/week, sustained for a minimum of 12 weeks before judging effect) as a foundational, grade-B/A-supported, drug-free adjunct; in dialysis-associated RLS, exercise plus a low dopamine-agonist dose achieved results similar to higher monotherapy doses, offering a plausible (though not yet proven in idiopathic RLS) route to lower drug exposure (2013-giannaki-exercise-dopamine-agonist-comparison.md, 2015-giannaki-exercise-dopamine-agonist-combination.md).
• Offer yoga (2x/week tapering to 1x/week, plus daily home practice) as a grade-B adjunct with a demonstrated dose-response relationship — more home-practice minutes track with greater symptom and sleep improvement, so patients should be counselled that consistency of practice, not just class attendance, likely drives benefit (2020-innes-yoga-educational-film-rct.md).
• Consider a supervised trial of magnesium (oxide, around 250 mg/day) and/or vitamin B6, but set expectations honestly: benefit may not appear before 2 months, and the overall evidence base remains mixed (2022-jadidi-magnesium-b6-rct.md versus 2019-marshall-magnesium-systematic-review.md).
• In dialysis-associated RLS specifically, vitamin C and/or E (200-400 mg/day) is a reasonably well- supported, low-risk adjunct; this evidence should not be extrapolated to non-dialysis idiopathic RLS without further study (2012-sagheb-vitamin-c-e-hemodialysis-rct.md).
• Address modifiable cardiometabolic/lifestyle risk (weight, smoking cessation, regular physical activity) as part of long-term RLS risk reduction, independent of acute symptom control, per the large prospective cohort evidence (2016-batool-anwar-lifestyle-factors-cohort.md) — but do not over-promise on caffeine restriction or generic "healthy eating," which were not supported as RLS-risk-modifying in the same cohort.
• Add a brief CBT-for-insomnia or an RLS-specific coping-focused group programme for patients with comorbid insomnia or high psychosocial burden from RLS, as a grade-B/C, drug-free way to reduce reliance on additional hypnotic medication (2020-song-cbti-rls-comorbid-insomnia-rct.md, 2008-hornyak-cbt-group-therapy-coping.md).
• Do not present vitamin D supplementation as an RLS-specific therapy absent confirmed deficiency; the one dedicated RCT was negative (2018-wali-vitamin-d-replacement-rct.md).
• Offer massage (lavender-oil or foot reflexology) or self-applied cold-water hydrotherapy as inexpensive, low-risk, patient-administered adjuncts with early RCT support, particularly for patients who dislike or cannot sustain structured exercise or yoga — while setting expectations that benefit may need ongoing, repeated application rather than a one-off course, since reflexology's benefit had faded by one month in the one RCT that followed patients that long (2021-doner-lavender-massage-hemodialysis-rct.md, 2022-ghanbari-reflexology-swedish-massage-rct.md, 2025-kubasch-hydrac-hydrotherapy-acupressure-rct.md).
• For patients carrying excess weight, discuss sustainable, medically supervised weight loss (including bariatric surgery where otherwise indicated) as a plausible, though not yet RCT-confirmed, avenue toward reduced RLS medication need, per the correlation between BMI reduction and RLS improvement in a 454-patient cohort and the high rate of medication discontinuation after sleeve gastrectomy in a small case series (2025-mutlu-bariatric-surgery-sleep-rls-cohort.md, 2019-ozdas-bariatric-surgery-rls-case-series.md) — recognizing that neither study used a control group and any medication change must remain physician-directed.
• All of the above are adjuncts to, not substitutes for, the guideline-directed iron-repletion and gabapentinoid-preferred pharmacological pathway described in the dopamine-agonists-augmentation.md synthesis; none of these lifestyle measures should be used to justify abrupt discontinuation of a dopamine agonist, which must always be tapered under physician supervision.

Open questions

• No RCT has tested whether a bundled lifestyle package (exercise plus yoga plus supplements plus iron repletion) enables successful dopamine-agonist or alpha-2-delta-ligand dose reduction or discontinuation as a primary endpoint; the existing drug-dose-comparison data come only from small, dialysis-specific trials (2013-giannaki-exercise-dopamine-agonist-comparison.md, 2015-giannaki-exercise-dopamine-agonist-combination.md).
• Long-term durability (beyond 3-6 months) of exercise, yoga, or supplement effects is essentially untested; nearly every RCT in this synthesis ran 6-16 weeks with limited or no follow-up.
• Almost all of the higher-quality exercise and vitamin C/E RCTs were conducted in hemodialysis-associated (secondary) RLS; whether the same effect sizes apply to idiopathic RLS in patients on long-term dopamine agonists or alpha-2-delta ligands (this project's target population) is largely unstudied.
• The mechanism behind magnesium's and vitamin C/E's apparent benefit (antioxidant effect, neuromuscular effect, or partial placebo/regression-to-the-mean) remains unresolved, and the magnesium literature specifically contains a direct contradiction between a null systematic review and more recent positive RCTs/pilots.
• Sexual activity/orgasm for symptom relief and compression stockings remain patient-reported anecdotal strategies mentioned in narrative reviews, but this search still did not locate a dedicated clinical study of sexual activity as an RLS intervention, and compression devices are covered separately by this project's devices-neuromodulation topic sweep rather than duplicated here. Cold-water hydrotherapy, previously in the same anecdotal category, now has one small exploratory pilot RCT (2025-kubasch-hydrac-hydrotherapy-acupressure-rct.md), but it was not powered for confirmatory efficacy and needs a larger, adequately powered follow-up trial.
• Whether "exercise" should be prescribed as aerobic, resistance, or stretching specifically matters, per the dissociation seen in the largest dialysis network meta-analysis (stretching significant, aerobic alone not; 2022-chen-component-network-meta-analysis-eskd.md), but no RCT has directly tested this distinction in idiopathic (non-dialysis) RLS.
• Whether massage, reflexology, or hydrotherapy benefits generalize beyond hemodialysis-associated RLS (massage/reflexology) or a small general-population pilot (hydrotherapy) to idiopathic RLS in patients on long-term dopamine agonists or alpha-2-delta ligands is untested by any identified RCT.
• Whether weight loss (surgical or lifestyle-driven) causally improves RLS, and by how much, remains unconfirmed by any controlled trial; the existing bariatric-surgery data are uncontrolled pre/post cohorts susceptible to confounding by other post-surgical metabolic and behavioural changes (2025-mutlu-bariatric-surgery-sleep-rls-cohort.md, 2019-ozdas-bariatric-surgery-rls-case-series.md). No RLS-specific Mediterranean-diet, folate/B12, or omega-3 fatty acid trial was located in this search despite dedicated queries, so these remain unstudied rather than merely unestablished.

Notes in this topic

Notes authored for this sweep:

• 2006-aukerman-exercise-rct.md - founding general-population RCT: 12-week aerobic+resistance exercise significantly improves RLS severity (p=.001).
• 2018-harrison-novel-exercises-rct.md - negative finding: weekly trauma-release/stretching exercise no better than discussion-group control at 6 weeks.
• 2018-harrison-nonpharm-systematic-review.md - systematic review of RCTs of non-pharmacologic RLS interventions; exercise most consistently supported.
• 2013-giannaki-aerobic-exercise-uremic-rct.md - RCT isolating true training effect: progressive resistance cycling beats zero-resistance cycling (58% vs 17% reduction).
• 2013-giannaki-exercise-dopamine-agonist-comparison.md - RCT: exercise training roughly matches low-dose ropinirole for RLS severity, adds lean-mass benefit.
• 2015-giannaki-exercise-dopamine-agonist-combination.md - RCT: exercise plus low-dose dopamine agonist equals exercise plus placebo (~60% reduction each).
• 2010-giannaki-single-bout-exercise-plm-hemodialysis.md - acute mechanistic study: single exercise bout suppresses periodic limb movements same-session.
• 2008-sakkas-intradialytic-exercise-pilot.md - first published intradialytic exercise pilot; 42% IRLS reduction (non-randomized allocation).
• 2017-song-exercise-hemodialysis-meta-analysis.md - meta-analysis of 15 RCTs: exercise significant for RLS, depression, fatigue (all p<0.001).
• 2020-huang-network-meta-analysis-esrd-treatments.md - network meta-analysis (12 RCTs): gabapentin ranks highest efficacy; exercise+dopamine agonist favorable on efficacy and acceptability.
• 2022-chen-component-network-meta-analysis-eskd.md - component network meta-analysis (24 RCTs): cool dialysate best overall; stretching and aromatherapy massage beat gabapentin numerically; aerobic exercise alone not significant.
• 2021-hargrove-aerobic-exercise-hemodialysis-symptoms.md - systematic review: aerobic exercise improves RLS, cramping, fatigue in hemodialysis (only 2/15 RCTs assessed RLS directly).
• 2013-mortazavi-aerobic-exercise-esrd-rct.md - RCT: aerobic exercise improves RLS signs but not overall quality of life.
• 2021-cederberg-physical-activity-ms-pilot-rct.md - pilot RCT: physical-activity behaviour-change program improves RLS severity in multiple sclerosis.
• 2022-ozdogar-exergaming-ms-rct.md - RCT: 8-week exergaming improves RLS severity, anxiety, sleep, and balance in MS-RLS, sustained at follow-up.
• 2012-innes-yoga-pilot-women.md - uncontrolled pilot: 8-week yoga produces large effect sizes and a practice-time dose-response.
• 2012-innes-yoga-older-women-nested-rct.md - nested RCT: yoga improves sleep, mood, and blood pressure in older women with RLS.
• 2020-innes-yoga-educational-film-rct.md - largest yoga RCT to date: yoga beats active educational-film control on RLS severity (p≤.01), with dose-response.
• 2023-akbas-progressive-muscle-relaxation-pregnancy-rct.md - RCT: progressive muscle relaxation improves RLS intensity, sleep, and quality of life in pregnancy.
• 2008-hornyak-cbt-group-therapy-coping.md - proof-of-concept RLS-specific CBT group therapy ("RELEGS") improves RLS-related quality of life, sustained to 3 months.
• 2020-song-cbti-rls-comorbid-insomnia-rct.md - RCT: CBT for insomnia improves sleep and anxiety in RLS patients with comorbid insomnia.
• 2012-sagheb-vitamin-c-e-hemodialysis-rct.md - RCT (n=60): vitamin C, E, and combination all significantly reduce RLS severity in hemodialysis patients.
• 2024-gorantla-magnesium-citrate-open-label-pilot.md - open-label pilot: magnesium citrate improves IRLS score and objective PLM-wakefulness measures.
• 2019-marshall-magnesium-systematic-review.md - systematic review: magnesium evidence inconclusive (one null RCT, mostly case reports).
• 2022-jadidi-magnesium-b6-rct.md - RCT (n=75): magnesium and vitamin B6 both significantly better than placebo by 2 months.
• 2024-gonzalez-parejo-dietary-supplements-systematic-review.md - systematic review (10 RCTs, 482 patients): magnesium/B6, vitamin C, vitamin E positive; vitamin D not significant.
• 2018-wali-vitamin-d-replacement-rct.md - negative RCT: high-dose vitamin D does not improve RLS severity despite raising serum levels.
• 2016-batool-anwar-lifestyle-factors-cohort.md - prospective cohort (n=55,540): weight, physical activity, smoking, and alcohol each modify RLS risk; caffeine and diet quality do not.
• 2022-belcaro-pycnogenol-registry-study.md - non-randomized registry study: Pycnogenol improves RLS symptoms and venoarteriolar response.
• 2021-doner-lavender-massage-hemodialysis-rct.md - RCT (n=58): lavender-oil intradialytic massage significantly reduces RLS severity and improves quality of life versus baby-oil control.
• 2022-ghanbari-reflexology-swedish-massage-rct.md - three-arm RCT (n=90): foot reflexology beats Swedish massage and sham touch immediately post-intervention, but benefit fades by one month in all arms.
• 2016-gopaluni-cochrane-ckd-rls-interventions.md - Cochrane systematic review (9 RCTs, 220 patients): confirms exercise benefit but concludes CKD-RLS interventions overall have "uncertain effects."
• 2025-kubasch-hydrac-hydrotherapy-acupressure-rct.md - three-arm pilot RCT (n=54): self-applied cold-water hydrotherapy and acupressure show numerically better IRLS/quality-of-life than routine care alone.
• 2025-mutlu-bariatric-surgery-sleep-rls-cohort.md - cohort (n=454): RLS severity falls significantly after bariatric surgery, correlated with amount of BMI reduction.
• 2019-ozdas-bariatric-surgery-rls-case-series.md - case series (n=14): 86% of patients discontinue RLS medication 12 months after sleeve gastrectomy alongside major BMI reduction.
• 2025-alabdulqader-caffeine-smoking-medical-students.md - cross-sectional survey (n=331): higher caffeine intake associated with RLS, contradicting the larger Batool-Anwar cohort's null finding.
• 2020-guay-scoping-review-manual-nonpharm-therapies.md - scoping review (24 studies): rates exercise, acupuncture, pneumatic compression, and near-infrared light as most consistently effective; yoga and massage flagged as needing more study.

Pre-existing/concurrently-authored notes found in the knowledge base, also relevant to this topic:

• 2018-harrison-nonpharm-systematic-review.md (PMID 29561180) - covers the device-focused modalities (vibration, tDCS, near-infrared light, pneumatic compression, rTMS, acupuncture, cryotherapy) from this same systematic review; a second note with an "-rct" filename was drafted concurrently by the devices-neuromodulation topic sweep but was a duplicate of this one and was not kept (corrected 2026-09). Compression, vibration, thermal, and electrical-stimulation modalities are covered by that sweep rather than duplicated here.
• No other pre-existing notes in the knowledge base as of this sweep carried lifestyle/exercise/diet/ supplement content specific to RLS; the searches run for this topic (see below) turned up no additional overlap with the original 191-note knowledge base.

Additional linked notes (2026-09 quality pass)

These notes carry this topic tag but are not yet woven into the prose synthesis above; listed here so they are discoverable and counted in catalog.json rather than orphaned.

• 2016-aliasgharpour-stretching-exercise-hemodialysis-rls.md (2016) - The Effect of Stretching Exercises on Severity of Restless Legs Syndrome in Patients on Hemodialysis: In a small clinical trial of 33 hemodialysis patients with RLS, in-dialysis leg stretching exercises (30 minutes, 3×/week for 8 weeks) significantly reduced RLS symptom severity in the intervention group (n = 17) comp...
• 2019-nasiri-olive-oil-massage-uremic-rls.md (2019) - Short-term effects of massage with olive oil on the severity of uremic restless legs syndrome: A double-blind placebo-controlled trial: In a double-blind, placebo-controlled RCT of 60 hemodialysis patients with uremic RLS, twice-weekly olive oil leg massage for 3 weeks significantly reduced RLS severity compared with placebo (liquid paraffin) massage ...
• 2021-ghasemi-aromatherapy-reflexology-hemodialysis-rls.md (2021) - Aromatherapy Massage vs. Foot Reflexology on the Severity of Restless Legs Syndrome in Female Patients Undergoing Hemodialysis: In a 3-arm, placebo-controlled RCT of 105 female hemodialysis patients (35/arm), aromatherapy massage with lavender oil significantly reduced RLS severity over 8 weeks (24 sessions), whereas foot reflexology did not d...
• 2024-giannaki-exercise-sleep-disorders.md (2024) - Unfolding the role of exercise in the management of sleep disorders: This narrative review, co-authored by researchers at the University of Nicosia (Cyprus), University of Thessaly and University of Cyprus (Greek/Cypriot academic network), summarizes evidence that regular exercise — ae...
• 2025-ozdogar-nonpharm-sleep-ms-metaanalysis.md (2025) - The Efficacy of Non-Pharmacological Interventions for Sleep Disorders in People With Multiple Sclerosis: A Systematic Review and Meta-Analysis: This systematic review and random-effects meta-analysis (PRISMA-guided, searched through April 2024), co-authored by Alon Kalron of Tel-Aviv University and the Sheba Medical Center Multiple Sclerosis Center (Israel), ...